To include your compound in the COVID-19 Resource Center, submit it here.

Encore, Myriad Genetics deal

MYGN acquired exclusive worldwide rights from Encore to E-7869

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE